siRNA, Anti-ANKRD13A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT51272WQ-2OMe)

The product SIRGT51272WQ-2OMe is a type of small interfering RNA (siRNA) that targets ANKRD13A gene and regulates the expression of gene. The siRNA interferes with the expression of ANKRD13A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_033121.1
Alternative Names ANKRD13; NY-REN-25
Related Diseases Anterior Segment Dysgenesis 5
Purification HPLC
Target Gene
Gene ID 88455
Uniprot ID Q8IZ07
Sub Cat Target Species Modification Scale  
SIRGT52272WQ-2F ANKRD13A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT53272WQ-2MOE ANKRD13A Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT54272WQ-LNA ANKRD13A Human Locked Nucleic Acid (LNA) Inquiry
SIRGT51272WQ-RB ANKRD13A Human Ribo-modified Inquiry
SIRGT52272WQ-BB ANKRD13A Human Backbone-modified Inquiry

Related Products